Myriad Genetics Inc (MYGN)
13.65
+0.29
(+2.17%)
USD |
NASDAQ |
Dec 23, 16:00
13.65
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Shareholders Equity (Quarterly): 731.70M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Haemonetics Corp | 878.85M |
| Boston Scientific Corp | 20.71B |
| Globus Medical Inc | 4.069B |
| ResMed Inc | 5.195B |
| Perspective Therapeutics Inc | 328.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.081B |
| Total Liabilities (Quarterly) | 349.60M |
| Debt to Equity Ratio | 0.0533 |
| Current Ratio | 1.900 |
| Net Debt Paydown Yield | -0.00% |